Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species
RGS10 plays a role in chemoresistance in ovarian cancer. Loss of RGS10 enhances survival among these cells.
RGS10 could serve in a novel, and previously unknown, role by accelerating the hydrolysis of GTP (show AK3 ELISA Kits) from Rheb (show RHEB ELISA Kits) in ovarian cancer cells.
Inhibition of HDAC1 (show HDAC1 ELISA Kits) and DNMT1 (show DNMT1 ELISA Kits) modulate RGS10 expression and decrease ovarian cancer chemoresistance.
The results suggest unaltered membrane RGS4 (show RGS4 ELISA Kits) and cytosolic RGS10 proteins levels in schizophrenia and major depression.
Data show that that SPL/RGS/SHP1 complexes are present in resting platelets where constitutive phosphorylation of SPL(Y398) creates an atypical binding site for SHP-1.
RGS10 is a key molecule that contributes to the inhibition of Galpha (show SUCLG1 ELISA Kits)-dependent signaling during chemokine (show CCL1 ELISA Kits)-activated alpha4beta1- and alphaLbeta2-dependent T cell adhesion.
RGS10 and RGS4 (show RGS4 ELISA Kits) proteins are both detected in postmortem prefrontal cortex.
Results establish RGS10 and RGS17 (show RGS17 ELISA Kits) as novel regulators of cell survival and chemoresistance in ovarian cancer cells and suggest that their reduced expression may be diagnostic of chemoresistance.
Results demonstrate the specificity of RGS10A as a key component in the RANKL (show TNFSF11 ELISA Kits)-evoked signaling pathway for osteoclast differentiation.
These data demonstrate a critical role for RGS10 in mediating autoimmune disease through regulation of T lymphocyte function.
data indicate that Rgs10-/- macrophages displayed dysregulated M1 responses along with blunted M2 alternative activation responses
we identified protein kinase A and the downstream phospho-cAMP response element-binding signaling pathway as key mediators of the neuroprotective effect of RGS10 against inflammatory stress
RGS10 negatively regulates nuclear factor kappaB activation and production pathway in microglia and demonstrates the neuroprotective effects of microglial RGS10 gene transfer in a rat model of parkinsonism.
mechanism through which RGS10 specifically regulates the RANKL (show TNFSF11 ELISA Kits)-evoked RGS10/calmodulin-[Ca2 (show CA2 ELISA Kits)+]i oscillation-calcineurin (show PPP3CA ELISA Kits)-NFATc1 (show NFATC1 ELISA Kits) signaling pathway in osteoclast differentiation
Limits microglial-derived TNF (show TNF ELISA Kits) secretion and regulates functional outcome of inflammatory stimuli in tventral midbrain. Novel drug target for prevention of nigrostriatal pathway degeneration, neuropathological hallmark of Parkinson's disease.
Regulator of G protein signaling (RGS) family members are regulatory molecules that act as GTPase activating proteins (GAPs) for G alpha subunits of heterotrimeric G proteins. RGS proteins are able to deactivate G protein subunits of the Gi alpha, Go alpha and Gq alpha subtypes. They drive G proteins into their inactive GDP-bound forms. Regulator of G protein signaling 10 belongs to this family. All RGS proteins share a conserved 120-amino acid sequence termed the RGS domain. This protein associates specifically with the activated forms of the two related G-protein subunits, G-alphai3 and G-alphaz but fails to interact with the structurally and functionally distinct G-alpha subunits. Regulator of G protein signaling 10 protein is localized in the nucleus. Two transcript variants encoding different isoforms have been found for this gene.
regulator of G-protein signalling 10
, regulator of G-protein signaling 10